Literature DB >> 22330677

Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus.

Nahuel Fittipaldi1, Stephen B Beres, Randall J Olsen, Vivek Kapur, Patrick R Shea, M Ebru Watkins, Concepcion C Cantu, Daniel R Laucirica, Leslie Jenkins, Anthony R Flores, Marguerite Lovgren, Carmen Ardanuy, Josefina Liñares, Donald E Low, Gregory J Tyrrell, James M Musser.   

Abstract

Group A Streptococcus (GAS) causes an exceptionally broad range of infections in humans, from relatively mild pharyngitis and skin infections to life-threatening necrotizing fasciitis and toxic shock syndrome. An epidemic of severe invasive human infections caused by type emm59 GAS, heretofore an exceedingly rare cause of disease, spread west to east across Canada over a 3-year period (2006 to 2008). By sequencing the genomes of 601 epidemic, historic, and other emm59 organisms, we discovered that a recently emerged, genetically distinct emm59 clone is responsible for the Canadian epidemic. Using near-real-time genome sequencing, we were able to show spread of the Canadian epidemic clone into the United States. The extensive genome data permitted us to identify patterns of geographic dissemination as well as links between emm59 subclonal lineages that cause infections. Mouse and nonhuman primate models of infection demonstrated that the emerged clone is unusually virulent. Transmission of epidemic emm59 strains may have occurred primarily by skin contact, as suggested by an experimental model of skin transmission. In addition, the emm59 strains had a significantly impaired ability to persist in human saliva and to colonize the oropharynx of mice, and seldom caused human pharyngitis. Our study contributes new information to the rapidly emerging field of molecular pathogenomics of bacterial epidemics and illustrates how full-genome data can be used to precisely illuminate the landscape of strain dissemination during a bacterial epidemic.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22330677     DOI: 10.1016/j.ajpath.2011.12.037

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Population genomics: an investigative tool for epidemics.

Authors:  Debra E Bessen
Journal:  Am J Pathol       Date:  2012-02-28       Impact factor: 4.307

2.  Polymorphisms in Regulator of Cov Contribute to the Molecular Pathogenesis of Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Jesus M Eraso; Luchang Zhu; Jessica E Madry; Sarah E Linson; Matthew Ojeda Saavedra; Concepcion Cantu; James M Musser; Randall J Olsen
Journal:  Am J Pathol       Date:  2019-07-29       Impact factor: 4.307

Review 3.  Molecular epidemiology and genomics of group A Streptococcus.

Authors:  Debra E Bessen; W Michael McShan; Scott V Nguyen; Amol Shetty; Sonia Agrawal; Hervé Tettelin
Journal:  Infect Genet Evol       Date:  2014-10-30       Impact factor: 3.342

4.  Comparative pathogenomic characterization of a non-invasive serotype M71 strain Streptococcus pyogenes NS53 reveals incongruent phenotypic implications from distinct genotypic markers.

Authors:  Yun-Juan Bao; Yang Li; Zhong Liang; Garima Agrahari; Shaun W Lee; Victoria A Ploplis; Francis J Castellino
Journal:  Pathog Dis       Date:  2017-07-31       Impact factor: 3.166

5.  Clinical laboratory response to a mock outbreak of invasive bacterial infections: a preparedness study.

Authors:  Randall J Olsen; Nahuel Fittipaldi; Priyanka Kachroo; Misu A Sanson; S Wesley Long; Kathryn J Como-Sabetti; Chandni Valson; Concepcion Cantu; Ruth Lynfield; Chris Van Beneden; Stephen B Beres; James M Musser
Journal:  J Clin Microbiol       Date:  2014-09-24       Impact factor: 5.948

6.  Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.

Authors:  Waleed Nasser; Stephen B Beres; Randall J Olsen; Melissa A Dean; Kelsey A Rice; S Wesley Long; Karl G Kristinsson; Magnus Gottfredsson; Jaana Vuopio; Kati Raisanen; Dominique A Caugant; Martin Steinbakk; Donald E Low; Allison McGeer; Jessica Darenberg; Birgitta Henriques-Normark; Chris A Van Beneden; Steen Hoffmann; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

7.  Phosphorylation events in the multiple gene regulator of group A Streptococcus significantly influence global gene expression and virulence.

Authors:  Misu Sanson; Nishanth Makthal; Maire Gavagan; Concepcion Cantu; Randall J Olsen; James M Musser; Muthiah Kumaraswami
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

8.  Strain-Dependent Effect of Capsule on Transmission and Persistence in an Infant Mouse Model of Group A Streptococcus Infection.

Authors:  Luis Alberto Vega; Misu A Sanson; Brittany J Shah; Anthony R Flores
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

9.  High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of Uncommon emm Types in Thunder Bay, Ontario, Canada.

Authors:  Taryn B T Athey; Sarah Teatero; Lee E Sieswerda; Jonathan B Gubbay; Alex Marchand-Austin; Aimin Li; Jessica Wasserscheid; Ken Dewar; Allison McGeer; David Williams; Nahuel Fittipaldi
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

10.  A molecular trigger for intercontinental epidemics of group A Streptococcus.

Authors:  Luchang Zhu; Randall J Olsen; Waleed Nasser; Stephen B Beres; Jaana Vuopio; Karl G Kristinsson; Magnus Gottfredsson; Adeline R Porter; Frank R DeLeo; James M Musser
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.